These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 38203699)
21. Development of Muharram MM; Abulhamd AT; Aldawsari MF; Alqarni MH; Labrou NE Antibiotics (Basel); 2020 Mar; 9(4):. PubMed ID: 32235599 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the Lytic Capability of a LysK-Like Endolysin, Lys-phiSA012, Derived from a Polyvalent Staphylococcus aureus Bacteriophage. Fujiki J; Nakamura T; Furusawa T; Ohno H; Takahashi H; Kitana J; Usui M; Higuchi H; Tanji Y; Tamura Y; Iwano H Pharmaceuticals (Basel); 2018 Feb; 11(1):. PubMed ID: 29495305 [TBL] [Abstract][Full Text] [Related]
23. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Sass P; Bierbaum G Appl Environ Microbiol; 2007 Jan; 73(1):347-52. PubMed ID: 17085695 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic Potential of an Endolysin Derived from Kayvirus S25-3 for Staphylococcal Impetigo. Imanishi I; Uchiyama J; Tsukui T; Hisatsune J; Ide K; Matsuzaki S; Sugai M; Nishifuji K Viruses; 2019 Aug; 11(9):. PubMed ID: 31443379 [TBL] [Abstract][Full Text] [Related]
25. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region. Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780 [TBL] [Abstract][Full Text] [Related]
26. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777 [TBL] [Abstract][Full Text] [Related]
27. Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. Rodríguez-Rubio L; Martínez B; Rodríguez A; Donovan DM; García P Appl Environ Microbiol; 2012 Apr; 78(7):2241-8. PubMed ID: 22267667 [TBL] [Abstract][Full Text] [Related]
28. [Lytic action of lysoamidase from Xanthomonas sp. correlates with the presence of the target ribitol teichoic acids in the cell wall of gram-positive bacteria]. Kulaev IS; Naumova IB; Streshinskaia GM; Tul'skaia EM; Stepnaia OA; Severin AI; Begunova EA Mikrobiologiia; 1996; 65(3):326-32. PubMed ID: 8992241 [TBL] [Abstract][Full Text] [Related]
29. An Engineered Multimodular Enzybiotic against Methicillin-Resistant Manoharadas S; Altaf M; Alrefaei AF; Ahmad N; Althaf Hussain S; Al-Rayes BF Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947915 [TBL] [Abstract][Full Text] [Related]
30. Lysis of cells of diverse bacteria by l,d-peptidases of Escherichia coli bacteriophages RB43, RB49 and T5. Shadrin VS; Machulin AV; Dorofeeva LV; Chernyshov SV; Mikoulinskaia GV J Appl Microbiol; 2021 Jun; 130(6):1902-1912. PubMed ID: 33107183 [TBL] [Abstract][Full Text] [Related]
31. Characterization of staphylococcal endolysin LysSAP33 possessing untypical domain composition. Yu JH; Park DW; Lim JA; Park JH J Microbiol; 2021 Sep; 59(9):840-847. PubMed ID: 34383247 [TBL] [Abstract][Full Text] [Related]
32. The structure and function of modular Escherichia coli O157:H7 bacteriophage FTBEc1 endolysin, LysT84: defining a new endolysin catalytic subfamily. Love MJ; Coombes D; Ismail S; Billington C; Dobson RCJ Biochem J; 2022 Jan; 479(2):207-223. PubMed ID: 34935873 [TBL] [Abstract][Full Text] [Related]
33. PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related Species. Blázquez B; Fresco-Taboada A; Iglesias-Bexiga M; Menéndez M; García P Front Microbiol; 2016; 7():1156. PubMed ID: 27516758 [TBL] [Abstract][Full Text] [Related]
34. Phage endolysins with broad antimicrobial activity against Enterococcus faecalis clinical strains. Proença D; Fernandes S; Leandro C; Silva FA; Santos S; Lopes F; Mato R; Cavaco-Silva P; Pimentel M; São-José C Microb Drug Resist; 2012 Jun; 18(3):322-32. PubMed ID: 22480295 [TBL] [Abstract][Full Text] [Related]
35. Decoding the Structure-Function Relationship of the Muramidase Domain in E. coli O157.H7 Bacteriophage Endolysin: A Potential Building Block for Chimeric Enzybiotics. Javid M; Shahverdi AR; Ghasemi A; Moosavi-Movahedi AA; Ebrahim-Habibi A; Sepehrizadeh Z Protein J; 2024 Jun; 43(3):522-543. PubMed ID: 38662183 [TBL] [Abstract][Full Text] [Related]
37. Bacteriophage φEf11 ORF28 Endolysin, a Multifunctional Lytic Enzyme with Properties Distinct from All Other Identified Enterococcus faecalis Phage Endolysins. Zhang H; Buttaro BA; Fouts DE; Sanjari S; Evans BS; Stevens RH Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 30979842 [TBL] [Abstract][Full Text] [Related]
38. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens. Basit A; Qadir S; Qureshi S; Rehman SU Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883 [TBL] [Abstract][Full Text] [Related]
39. Development of Advanced Chimeric Endolysin to Control Multidrug-Resistant Lee C; Kim J; Son B; Ryu S ACS Infect Dis; 2021 Aug; 7(8):2081-2092. PubMed ID: 34047546 [TBL] [Abstract][Full Text] [Related]
40. Current Status of Endolysin-Based Treatments against Gram-Negative Bacteria. Gontijo MTP; Jorge GP; Brocchi M Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]